NASDAQ
MIRA Pharmaceuticals, Inc. (MIRA) has a free cash flow growth of -5.84% as of Friday, May 29, 2026. This represents a 216.80% decrease compared to its 12-month average of 5.00%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.